
The field of hepatitis C treatment has two new groundbreaking medicines to treat the condition.Merck’s Victrelis (boceprevir) and Johnson & …

The FDA has approved Merck’s hepatitis C drug Victrelis, the first oral treatment for the disease. Victrelis (boceprevir) has been …

This year is expected to see new treatments for hepatitis C, multiple sclerosis and lupus among those that could reach …
Merck’s new oral hepatitis C drug boceprevir will receive fast track reviews from both the FDA and the EMA after …

